scholarly journals Long-term survival analysis of the randomized phase II trial investigating the addition of carboplatin to neoadjuvant therapy for triple-negative (TNBC) and HER2-positive early breast cancer (GeparSixto)

2017 ◽  
Vol 28 ◽  
pp. v49 ◽  
Author(s):  
M. Untch ◽  
A. Schneeweiss ◽  
C. Salat ◽  
M. Rezai ◽  
D-M. Zahm ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Survival Analysis ◽  
Neoadjuvant Therapy ◽  
Early Breast Cancer ◽  
Triple Negative ◽  
Phase Ii Trial ◽  
Her2 Positive ◽  
Term Survival ◽  
Randomized Phase Ii

scholarly journals Long term survival of HER2-positive early breast cancer treated with trastuzumab-based adjuvant regimen: A large cohort study from clinical practice

The Breast ◽  
2014 ◽  
Vol 23 (5) ◽  
pp. 573-578 ◽  
Author(s):  
Martina Bonifazi ◽  
Matteo Franchi ◽  
Marta Rossi ◽  
Alberto Zambelli ◽  
Lorenzo Moja ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Clinical Practice ◽  
Early Breast Cancer ◽  
Large Cohort ◽  
Her2 Positive ◽  
Term Survival ◽  
Long Term Survival ◽  
Large Cohort Study
Sign in / Sign up

Export Citation Format

Share Document